OBJECTIVE: To identify determinants of musculoskeletal deficits (muscle cross-sectional area [mCSA], trabecular volumetric bone mineral density [vBMD], and cortical bone strength [section modulus]) in patients with juvenile idiopathic arthritis (JIA) and to determine if cortical bone strength is appropriately adapted to muscle forces. METHODS: Peripheral quantitative computed tomography (pQCT) of the tibia was performed in 101 patients with JIA (79% female; 24 with oligoarticular JIA, 40 with polyarticular JIA, 18 with systemic JIA, and 19 with spondylarthritis [SpA]) and 830 healthy control subjects; all were ages 5-22 years. Outcomes of pQCT were expressed as sex- and race-specific Z scores. Multivariable linear regression models assessed mCSA and bone status in JIA patients compared with controls and identified factors associated with musculoskeletal deficits in JIA. RESULTS: The median duration of JIA was 40 months; 29% of the JIA patients had active arthritis, and 28% had received glucocorticoid therapy during the previous year. Compared with the controls, the mCSA and section modulus Z scores were significantly lower in patients with polyarticular JIA and those with SpA. Trabecular vBMD Z scores were significantly lower in patients with polyarticular JIA, those with systemic JIA, and those with SpA. Significant predictors of musculoskeletal deficits included active arthritis in the previous 6 months (mCSA), temporomandibular joint disease (mCSA and section modulus), functional disability (mCSA and vBMD), short stature (vBMD), infliximab exposure (vBMD), and JIA duration (section modulus). The section modulus was significantly reduced relative to mCSA in patients with JIA after adjustment for age and limb length. CONCLUSION: Marked deficits in vBMD and bone strength occur in JIA in association with severe and longstanding disease. Contrary to the findings of previous studies, bone deficits were greater than expected relative to the mCSA, which illustrates the importance of adjusting for age and bone length.
OBJECTIVE: To identify determinants of musculoskeletal deficits (muscle cross-sectional area [mCSA], trabecular volumetric bone mineral density [vBMD], and cortical bone strength [section modulus]) in patients with juvenile idiopathic arthritis (JIA) and to determine if cortical bone strength is appropriately adapted to muscle forces. METHODS: Peripheral quantitative computed tomography (pQCT) of the tibia was performed in 101 patients with JIA (79% female; 24 with oligoarticular JIA, 40 with polyarticular JIA, 18 with systemic JIA, and 19 with spondylarthritis [SpA]) and 830 healthy control subjects; all were ages 5-22 years. Outcomes of pQCT were expressed as sex- and race-specific Z scores. Multivariable linear regression models assessed mCSA and bone status in JIA patients compared with controls and identified factors associated with musculoskeletal deficits in JIA. RESULTS: The median duration of JIA was 40 months; 29% of the JIA patients had active arthritis, and 28% had received glucocorticoid therapy during the previous year. Compared with the controls, the mCSA and section modulus Z scores were significantly lower in patients with polyarticular JIA and those with SpA. Trabecular vBMD Z scores were significantly lower in patients with polyarticular JIA, those with systemic JIA, and those with SpA. Significant predictors of musculoskeletal deficits included active arthritis in the previous 6 months (mCSA), temporomandibular joint disease (mCSA and section modulus), functional disability (mCSA and vBMD), short stature (vBMD), infliximab exposure (vBMD), and JIA duration (section modulus). The section modulus was significantly reduced relative to mCSA in patients with JIA after adjustment for age and limb length. CONCLUSION: Marked deficits in vBMD and bone strength occur in JIA in association with severe and longstanding disease. Contrary to the findings of previous studies, bone deficits were greater than expected relative to the mCSA, which illustrates the importance of adjusting for age and bone length.
Authors: Jon M Burnham; Justine Shults; Moira A Petit; Edisio Semeao; Thomas J Beck; Babette S Zemel; Mary B Leonard Journal: J Bone Miner Res Date: 2007-04 Impact factor: 6.741
Authors: Daniel J Lovell; Andreas Reiff; Olcay Y Jones; Rayfel Schneider; James Nocton; Leonard D Stein; Abraham Gedalia; Norman T Ilowite; Carol A Wallace; James B Whitmore; Barbara White; Edward H Giannini Journal: Arthritis Rheum Date: 2006-06
Authors: Robert S Weinstein; Jin-Ran Chen; Cara C Powers; Scott A Stewart; Reid D Landes; Teresita Bellido; Robert L Jilka; A Michael Parfitt; Stavros C Manolagas Journal: J Clin Invest Date: 2002-04 Impact factor: 14.808
Authors: Cynthia L Ogden; Robert J Kuczmarski; Katherine M Flegal; Zuguo Mei; Shumei Guo; Rong Wei; Laurence M Grummer-Strawn; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Pediatrics Date: 2002-01 Impact factor: 7.124
Authors: Sarah E Dubner; Justine Shults; Mary B Leonard; Babette S Zemel; Harjeet Sembhi; Jon M Burnham Journal: J Clin Densitom Date: 2008-03-04 Impact factor: 2.617
Authors: Sogol Mostoufi-Moab; Jill P Ginsberg; Nancy Bunin; Babette Zemel; Justine Shults; Mary B Leonard Journal: J Bone Miner Res Date: 2012-04 Impact factor: 6.741
Authors: Joshua F Baker; Matthew Davis; Ruben Alexander; Babette S Zemel; Sogol Mostoufi-Moab; Justine Shults; Michael Sulik; Daniel J Schiferl; Mary B Leonard Journal: Bone Date: 2012-12-11 Impact factor: 4.398
Authors: Arseniy M Smirnov; Grigory S Demin; Marina M Mnuskina; Larisa A Scheplyagina; Mikhail M Kostik; Valentina I Larionova Journal: EPMA J Date: 2013-06-13 Impact factor: 6.543